These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15876202)

  • 1. Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk.
    Brand KP; Zielinski JM; Krewski D
    Risk Anal; 2005 Apr; 25(2):253-69. PubMed ID: 15876202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population attributable fraction for lung cancer due to residential radon in Switzerland and Germany.
    Menzler S; Piller G; Gruson M; Rosario AS; Wichmann HE; Kreienbrock L
    Health Phys; 2008 Aug; 95(2):179-89. PubMed ID: 18617799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating lung cancer mortality from residential radon using data for low exposures of miners.
    Lubin JH; Tomásek L; Edling C; Hornung RW; Howe G; Kunz E; Kusiak RA; Morrison HI; Radford EP; Samet JM; Tirmarche M; Woodward A; Yao SX
    Radiat Res; 1997 Feb; 147(2):126-34. PubMed ID: 9008203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette use and the estimation of lung cancer attributable to radon in the United States.
    Lubin JH; Steindorf K
    Radiat Res; 1995 Jan; 141(1):79-85. PubMed ID: 7997518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoor radon and lung cancer risk in connecticut and utah.
    Sandler DP; Weinberg CR; Shore DL; Archer VE; Stone MB; Lyon JL; Rothney-Kozlak L; Shepherd M; Stolwijk JA
    J Toxicol Environ Health A; 2006 Apr; 69(7):633-54. PubMed ID: 16608830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of radon and lung cancer in New Jersey.
    Wilcox HB; Al-Zoughool M; Garner MJ; Jiang H; Klotz JB; Krewski D; Nicholson WJ; Schoenberg JB; Villeneuve PJ; Zielinski JM
    Radiat Prot Dosimetry; 2008; 128(2):169-79. PubMed ID: 17611199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residential radon exposure and lung cancer: variation in risk estimates using alternative exposure scenarios.
    Field RW; Smith BJ; Steck DJ; Lynch CF
    J Expo Anal Environ Epidemiol; 2002 May; 12(3):197-203. PubMed ID: 12032816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined analysis of North American case-control studies of residential radon and lung cancer.
    Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of uncertainty and variability in residential radon cancer risks.
    Krewski D; Rai SN; Zielinski JM; Hopke PK
    Ann N Y Acad Sci; 1999; 895():245-72. PubMed ID: 10676422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residential radon and lung cancer: end of the story?
    Samet JM
    J Toxicol Environ Health A; 2006 Apr; 69(7):527-31. PubMed ID: 16608827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radon exposure assessment and dosimetry applied to epidemiology and risk estimation.
    Puskin JS; James AC
    Radiat Res; 2006 Jul; 166(1 Pt 2):193-208. PubMed ID: 16808608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners.
    Morrison HI; Villeneuve PJ; Lubin JH; Schaubel DE
    Radiat Res; 1998 Jul; 150(1):58-65. PubMed ID: 9650603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Errors in exposure assessment, statistical power and the interpretation of residential radon studies.
    Lubin JH; Boice JD; Samet JM
    Radiat Res; 1995 Dec; 144(3):329-41. PubMed ID: 7494877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary lung cancer risk assessment of exposure to radon progeny for Transylvania, Romania.
    Truta-Popa LA; Dinu A; Dicu T; Szacsvai K; Cosma C; Hofmann W
    Health Phys; 2010 Sep; 99(3):301-7. PubMed ID: 20699690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian population risk of radon induced lung cancer: a re-assessment based on the recent cross-Canada radon survey.
    Chen J; Moir D; Whyte J
    Radiat Prot Dosimetry; 2012 Nov; 152(1-3):9-13. PubMed ID: 22874897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of lung cancer risk from residential radon exposure in Worcester county, Massachusetts.
    Thompson RE; Nelson DF; Popkin JH; Popkin Z
    Health Phys; 2008 Mar; 94(3):228-41. PubMed ID: 18301096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the North American residential radon and lung cancer case-control studies.
    Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indoor radon pollution in houses in the Apulian Region of Italy and evaluation of the probability of lung cancer in the population].
    L'Abbate N; Marcuccio P; Dipace C; Carbonara M; Carioggia E; Martucci V; Salamanna S; Simeone G; Vitucci L
    Med Lav; 2002; 93(6):527-39. PubMed ID: 12596423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of residential exposure to radon gas and lung cancer.
    Pavia M; Bianco A; Pileggi C; Angelillo IF
    Bull World Health Organ; 2003; 81(10):732-8. PubMed ID: 14758433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population attributable risk associated with lung cancer induced by residential radon in Canada: Sensitivity to relative risk model and radon probability density function choices: In memory of Professor Jan M. Zielinski.
    Al-Arydah M
    Sci Total Environ; 2017 Oct; 596-597():331-341. PubMed ID: 28437651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.